Fox News – Moderna announced Tuesday its fast-track designation awarded by the Food and Drug Administration (FDA) to accelerate the development of an effective COVID-19 vaccine. The purpose of fast track is to expedite the review of therapies and vaccines for serious conditions and fill an unmet medical need, Moderna officials wrote in a company statement.  FAUCI ‘CAUTIOUSLY OPTIMISTIC’ A CORONAVIRUS VACCINE CANDIDATE WILL BE EFFECTIVE.

More at Fox News

Comments are closed.